FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2168772783> ?p ?o ?g. }

• W2168772783 endingPage "5137" @default.
• W2168772783 startingPage "5126" @default.
• W2168772783 abstract "Purpose To evaluate potential detrimental effects of exemestane on bone and lipid metabolism. Patients and Methods Postmenopausal women with early breast cancer were randomly assigned to exemestane 25 mg daily or placebo for 2 years in a double-blind setting. Primary objective was to evaluate the effect of exemestane on bone mineral density. Secondary objectives were effects on bone biomarkers, plasma lipids, coagulation factors, and homocysteine. Planned size was 128 patients. Results One hundred forty-seven patients were enrolled. All patients completed their 24-month visit except for those discontinuing treatment at an earlier stage. The mean annual rate of bone mineral density loss was 2.17% v 1.84% in the lumbar spine (P = .568) and 2.72% v 1.48% in the femoral neck (P = .024) in the exemestane and placebo arm, respectively. The mean change in T-score after 2 years was −0.21 for exemestane and −0.11 on placebo in the hip, and −0.30 and −0.21, respectively, in the lumbar spine. Exemestane significantly increased serum level and urinary excretion of bone resorption, but also bone formation markers. Except for a modest reduction in high-density lipoprotein cholesterol (P < .001) and apolipoprotein A1 (P = .004), exemestane had no major effect on lipid profile, homocysteine levels, or coagulation parameters. Conclusion Exemestane modestly enhanced bone loss from the femoral neck without significant influence on lumbar bone loss. Except for a 6% to 9% drop in plasma high-density lipoprotein cholesterol, no major effects on serum lipids, coagulation factors, or homocysteine were recorded. Bone mineral density should be assessed according to the US Preventive Services Task Force guidelines." @default.
• W2168772783 created "2016-06-24" @default.
• W2168772783 creator A5012620771 @default.
• W2168772783 creator A5018226821 @default.
• W2168772783 creator A5026117965 @default.
• W2168772783 creator A5027296396 @default.
• W2168772783 creator A5031286476 @default.
• W2168772783 creator A5035837487 @default.
• W2168772783 creator A5036195539 @default.
• W2168772783 creator A5046622583 @default.
• W2168772783 creator A5047427579 @default.
• W2168772783 creator A5059334301 @default.
• W2168772783 creator A5075821880 @default.
• W2168772783 creator A5083634538 @default.
• W2168772783 date "2005-08-01" @default.
• W2168772783 modified "2023-10-16" @default.
• W2168772783 title "Effects of Exemestane Administered for 2 Years Versus Placebo on Bone Mineral Density, Bone Biomarkers, and Plasma Lipids in Patients With Surgically Resected Early Breast Cancer" @default.
• W2168772783 cites W1453600927 @default.
• W2168772783 cites W1562190372 @default.
• W2168772783 cites W1586699954 @default.
• W2168772783 cites W1928668153 @default.
• W2168772783 cites W1965505708 @default.
• W2168772783 cites W1980557732 @default.
• W2168772783 cites W1981476886 @default.
• W2168772783 cites W1981700496 @default.
• W2168772783 cites W1981922048 @default.
• W2168772783 cites W1989622431 @default.
• W2168772783 cites W1995876524 @default.
• W2168772783 cites W2006213735 @default.
• W2168772783 cites W2008789229 @default.
• W2168772783 cites W2045805069 @default.
• W2168772783 cites W2051034159 @default.
• W2168772783 cites W2070194977 @default.
• W2168772783 cites W2083281877 @default.
• W2168772783 cites W2101881391 @default.
• W2168772783 cites W2106601653 @default.
• W2168772783 cites W2107544225 @default.
• W2168772783 cites W2109076870 @default.
• W2168772783 cites W2111981448 @default.
• W2168772783 cites W2113264115 @default.
• W2168772783 cites W2116645872 @default.
• W2168772783 cites W2124038826 @default.
• W2168772783 cites W2127677509 @default.
• W2168772783 cites W2128291744 @default.
• W2168772783 cites W2133764838 @default.
• W2168772783 cites W2141528524 @default.
• W2168772783 cites W2141647078 @default.
• W2168772783 cites W2144238512 @default.
• W2168772783 cites W2145819414 @default.
• W2168772783 cites W2163688875 @default.
• W2168772783 cites W2169929115 @default.
• W2168772783 cites W2202169216 @default.
• W2168772783 cites W2230430502 @default.
• W2168772783 cites W2324075496 @default.
• W2168772783 cites W2343407300 @default.
• W2168772783 cites W2508460892 @default.
• W2168772783 cites W4237422067 @default.
• W2168772783 cites W4241546540 @default.
• W2168772783 cites W45937491 @default.
• W2168772783 cites W2105649266 @default.
• W2168772783 doi "https://doi.org/10.1200/jco.2005.07.097" @default.
• W2168772783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15983390" @default.
• W2168772783 hasPublicationYear "2005" @default.
• W2168772783 type Work @default.
• W2168772783 sameAs 2168772783 @default.
• W2168772783 citedByCount "261" @default.
• W2168772783 countsByYear W21687727832012 @default.
• W2168772783 countsByYear W21687727832013 @default.
• W2168772783 countsByYear W21687727832014 @default.
• W2168772783 countsByYear W21687727832015 @default.
• W2168772783 countsByYear W21687727832016 @default.
• W2168772783 countsByYear W21687727832017 @default.
• W2168772783 countsByYear W21687727832018 @default.
• W2168772783 countsByYear W21687727832019 @default.
• W2168772783 countsByYear W21687727832020 @default.
• W2168772783 countsByYear W21687727832021 @default.
• W2168772783 countsByYear W21687727832022 @default.
• W2168772783 countsByYear W21687727832023 @default.
• W2168772783 crossrefType "journal-article" @default.
• W2168772783 hasAuthorship W2168772783A5012620771 @default.
• W2168772783 hasAuthorship W2168772783A5018226821 @default.
• W2168772783 hasAuthorship W2168772783A5026117965 @default.
• W2168772783 hasAuthorship W2168772783A5027296396 @default.
• W2168772783 hasAuthorship W2168772783A5031286476 @default.
• W2168772783 hasAuthorship W2168772783A5035837487 @default.
• W2168772783 hasAuthorship W2168772783A5036195539 @default.
• W2168772783 hasAuthorship W2168772783A5046622583 @default.
• W2168772783 hasAuthorship W2168772783A5047427579 @default.
• W2168772783 hasAuthorship W2168772783A5059334301 @default.
• W2168772783 hasAuthorship W2168772783A5075821880 @default.
• W2168772783 hasAuthorship W2168772783A5083634538 @default.
• W2168772783 hasBestOaLocation W21687727831 @default.
• W2168772783 hasConcept C121608353 @default.
• W2168772783 hasConcept C126322002 @default.
• W2168772783 hasConcept C126894567 @default.
• W2168772783 hasConcept C134018914 @default.
• W2168772783 hasConcept C141071460 @default.
• W2168772783 hasConcept C142724271 @default.

• next